Health in tech director Timothy Hayes sells $16,248 in stock

Timothy Hayes, a director at Health In Tech, Inc. (HIT), divested shares of the company's Class A Common Stock, amounting to $16,248. The transactions took place on September 9 and September 11, 2026, with share prices fluctuating between $0.91 and $0.93 per share. On September 9, Hayes sold 5,730 shares at $0.93 each, followed by an additional 12,000 shares on September 11 at $0.91 per share.

As a result, Hayes now owns 120,780 shares of HIT's Class A Common Stock. The insider sale occurs amidst a declining stock trend, with HIT's shares dropping 53% over the past six months and 66% over the past year. Despite this bearish trend, experts deem the company undervalued, with shares trading close to their 52-week low of $0.85.

The Pro Research Report provides a more in-depth analysis of HIT, alongside insights on other US equities. Recently, Health In Tech disclosed a wider-than-anticipated loss for Q2 2026, reporting an adjusted loss of $0.04 per share, surpassing analysts' expectations of a $0.03 profit. The revenue decline was attributed to timing shifts due to a new carrier onboarding process, rather than reduced demand.

This earnings miss represents a $0.07 per share shortfall from analyst projections. These recent events shed light on HIT's present financial situation.